Olav Engebråten

Førsteamanuensis - Institutt for kreftforskning
Bilde av Olav Engebråten
English version of this page
Brukernavn
Besøksadresse Ullernchausseen 70 OUS Radiumhospitalet 0372 Oslo
Postadresse Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo

Publikasjoner

  • Morra, Anna; Schreurs, Maartje A. C.; Andrulis, Irene L.; Anton-Culver, Hoda; Augustinsson, Annelie & Beckmann, Matthias W. [Vis alle 125 forfattere av denne artikkelen] (2023). Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine. ISSN 2045-7634. 12(15), s. 16142–16162. doi: 10.1002/cam4.6272. Fulltekst i vitenarkiv
  • Mo, Torgeir; Brandal, Siri Helene Bertelsen; Geier, Oliver; Engebråten, Olav; Nilsen, Line & Kristensen, Vessela N. [Vis alle 10 forfattere av denne artikkelen] (2023). MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients. Cancers. ISSN 2072-6694. 15(18). doi: 10.3390/cancers15184662. Fulltekst i vitenarkiv
  • Levi, Hagai; Carmi, Shai; Rosset, Saharon; Yerushalmi, Rinat; Zick, Aviad & Yablonski-Peretz, Tamar [Vis alle 155 forfattere av denne artikkelen] (2023). Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics. ISSN 0022-2593. 60(12), s. 1186–1197. doi: 10.1136/jmg-2023-109185. Fulltekst i vitenarkiv
  • Figlioli, Gisella; Billaud, Amandine; Wang, Qin; Bolla, Manjeet K.; Dennis, Joe & Lush, Michael [Vis alle 96 forfattere av denne artikkelen] (2023). Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. Cancers. ISSN 2072-6694. 15(13). doi: 10.3390/cancers15133313. Fulltekst i vitenarkiv
  • Haugen, Mads; von der Lippe Gythfeldt, Hedda; Egeland, Eivind Valen; Normann, Lisa Svartdal; Pandya, Abhilash D. & Vedin, Lise-Lotte [Vis alle 15 forfattere av denne artikkelen] (2023). Liver X receptors induce antiproliferative effects in basal-like breast cancer. Molecular Oncology. ISSN 1574-7891. doi: 10.1002/1878-0261.13476. Fulltekst i vitenarkiv
  • Figlioli, Gisella; Billaud, Amandine; Ahearn, Thomas U.; Antonenkova, Natalia N.; Becher, Heiko & Beckmann, Matthias W. [Vis alle 114 forfattere av denne artikkelen] (2023). FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. European Journal of Human Genetics. ISSN 1018-4813. 31(5), s. 578–587. doi: 10.1038/s41431-022-01257-w. Fulltekst i vitenarkiv
  • Pettersen, Solveig; Øy, Geir Frode; Egeland, Eivind Valen; Juell, Siri; Engebråten, Olav & Mælandsmo, Gunhild Mari [Vis alle 7 forfattere av denne artikkelen] (2023). Breast cancer patient-derived explant cultures recapitulate in vivo drug responses. Frontiers in Oncology. ISSN 2234-943X. 13. doi: 10.3389/fonc.2023.1040665. Fulltekst i vitenarkiv
  • Morra, Anna; Mavaddat, Nasim; Muranen, Taru A.; Ahearn, Thomas U.; Allen, Jamie & Andrulis, Irene L. [Vis alle 84 forfattere av denne artikkelen] (2023). The impact of coding germline variants on contralateral breast cancer risk and survival. American Journal of Human Genetics. ISSN 0002-9297. 110(3), s. 475–486. doi: 10.1016/j.ajhg.2023.02.003. Fulltekst i vitenarkiv
  • Svartdal, Lisa Gregusson; Haugen, Mads; Hongisto, Vesa; Aure, Miriam Ragle; Leivonen, Suvi-Katri & Kristensen, Vessela N. [Vis alle 10 forfattere av denne artikkelen] (2023). High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. PLOS ONE. ISSN 1932-6203. 18(1). doi: 10.1371/journal.pone.0280507. Fulltekst i vitenarkiv
  • Mueller, Stefanie H.; Lai, Alvina G.; Valkovskaya, Maria; Michailidou, Kyriaki; Bolla, Manjeet K. & Wang, Qin [Vis alle 207 forfattere av denne artikkelen] (2023). Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Medicine. ISSN 1756-994X. 15(7). doi: 10.1186/s13073-022-01152-5. Fulltekst i vitenarkiv
  • Dixon-Suen, Suzanne C.; Lewis, Sarah; Martin, Richard M.; English, Dallas R.; Boyle, Terry & Giles, Graham G. [Vis alle 174 forfattere av denne artikkelen] (2022). Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. British Journal of Sports Medicine. ISSN 0306-3674. 56(20), s. 1157–1170. doi: 10.1136/bjsports-2021-105132.
  • Dorling, Leila; Carvalho, Sara; Allen, Jamie; Parsons, Michael T.; Fortuno, Cristina & Kristensen, Vessela N. [Vis alle 50 forfattere av denne artikkelen] (2022). Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Medicine. ISSN 1756-994X. 14(1), s. 1–17. doi: 10.1186/s13073-022-01052-8. Fulltekst i vitenarkiv
  • Bjørklund, Sunniva; Aure, Miriam Ragle; Häkkinen, Jari; Vallon-Christersson, Johan; Kumar, Surendra & Bull Evensen, Katrine [Vis alle 34 forfattere av denne artikkelen] (2022). Subtype and cell type specific expression of lncRNAs provide insight into breast cancer. Communications Biology. ISSN 2399-3642. 5(1), s. 1–14. doi: 10.1038/s42003-022-03559-7. Fulltekst i vitenarkiv
  • Mo, Torgeir; Brandal, Siri Helene Bertelsen; Kohn Luque, Alvaro; Engebråten, Olav; Kristensen, Vessela N. & Fleischer, Thomas [Vis alle 8 forfattere av denne artikkelen] (2022). Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer. Cancers. ISSN 2072-6694. 14(5), s. 1–16. doi: 10.3390/cancers14051326. Fulltekst i vitenarkiv
  • Dennis, Joe; Tyrer, Jonathan P.; Walker, Logan C.; Michailidou, Kyriaki; Dorling, Leila & Kristensen, Vessela N. [Vis alle 50 forfattere av denne artikkelen] (2022). Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology. ISSN 2399-3642. 5, s. 1–15. doi: 10.1038/s42003-021-02990-6. Fulltekst i vitenarkiv
  • Ahearn, Thomas U.; Zhang, Haoyu; Michailidou, Kyriaki; Milne, Roger L.; Bolla, Manjeet K. & Dennis, Joe [Vis alle 205 forfattere av denne artikkelen] (2022). Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research. ISSN 1465-5411. 24(1), s. 1–13. doi: 10.1186/s13058-021-01484-x. Fulltekst i vitenarkiv
  • Park, Hanla A.; Neumeyer, Sonja; Michailidou, Kyriaki; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Vis alle 50 forfattere av denne artikkelen] (2021). Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer. ISSN 0007-0920. 125(8), s. 1135–1145. doi: 10.1038/s41416-021-01432-8. Fulltekst i vitenarkiv
  • Johnson, Nichola; Maguire, Sarah; Morra, Anna; Kapoor, Pooja Middha; Tomczyk, Katarzyna & Kristensen, Vessela N. [Vis alle 50 forfattere av denne artikkelen] (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer. ISSN 0007-0920. 124, s. 842–854. doi: 10.1038/s41416-020-01185-w. Fulltekst i vitenarkiv
  • Rye, Inga Hansine; Huse, Kanutte; Josefsson, Sarah Elisabet; Kildal, Wanja; Danielsen, Håvard Emil Greger & Schlichting, Ellen [Vis alle 28 forfattere av denne artikkelen] (2021). Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Molecular Oncology. ISSN 1574-7891. 16(1), s. 88–103. doi: 10.1002/1878-0261.13047. Fulltekst i vitenarkiv
  • Morra, Anna; Escala-Garcia, Maria; Beesley, Jonathan; Keeman, Renske; Canisius, Sander & Ahearn, Thomas U. [Vis alle 50 forfattere av denne artikkelen] (2021). Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research. ISSN 1465-5411. 23:86(1), s. 1–18. doi: 10.1186/s13058-021-01450-7. Fulltekst i vitenarkiv
  • Haugen, Mads Haugland; Lingjærde, Ole Christian; Hedenfalk, Ingrid; Garred, Øystein; Borgen, Elin & Loman, Niklas [Vis alle 12 forfattere av denne artikkelen] (2021). Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers. JCO Precision Oncology (JCO PO). 5, s. 286–306. doi: 10.1200/PO.20.00086. Fulltekst i vitenarkiv
  • Park, JooYong; Choi, Ji-Yeob; Choi, Jaesung; Chung, Seokang; Song, Nan & Park, Sue K [Vis alle 50 forfattere av denne artikkelen] (2021). Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? Cancers. ISSN 2072-6694. 13:2370(10), s. 1–21. doi: 10.3390/cancers13102370. Fulltekst i vitenarkiv
  • Engebraaten, Olav; Yau, Christina; Berg, Kristian; Borgen, Elin; Garred, Øystein & Berstad, Maria Elisabeth Brandal [Vis alle 11 forfattere av denne artikkelen] (2021). RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer. Nature Communications. ISSN 2041-1723. 12(1). doi: 10.1038/s41467-021-26018-z. Fulltekst i vitenarkiv
  • Erdelyi, Katalin; Ditroi, Tamas; Johansson, Henrik J.; Czikora, Agnes; Balog, Noemi & Silwal-Pandit, Laxmi [Vis alle 19 forfattere av denne artikkelen] (2021). Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation. Proceedings of the National Academy of Sciences of the United States of America. ISSN 0027-8424. 118(45). doi: 10.1073/pnas.2100050118. Fulltekst i vitenarkiv
  • Krüger, Kristi; Silwal-Pandit, Laxmi; Wik, Elisabeth; Straume, Oddbjørn; Stefansson, Ingunn Marie & Borgen, Elin [Vis alle 10 forfattere av denne artikkelen] (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. Scientific Reports. ISSN 2045-2322. 11, s. 1–11. doi: 10.1038/s41598-021-81914-0. Fulltekst i vitenarkiv
  • Pandya, Abhilash D.; Iversen, Tore Geir; Moestue, Siver Andreas; Grinde, Maria Tunset; Mørch, Ýrr Asbjørg & Snipstad, Sofie [Vis alle 13 forfattere av denne artikkelen] (2021). Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft. Nanomaterials. ISSN 2079-4991. 11(5). doi: 10.3390/nano11051140. Fulltekst i vitenarkiv
  • Barkovskaya, Anna; Goodwin, Craig; Seip, Kotryna; Hilmarsdòttir, Bylgja; Pettersen, Solveig & Stalnecker, Clint [Vis alle 13 forfattere av denne artikkelen] (2021). Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen. Molecular Oncology. ISSN 1574-7891. 15(8), s. 2026–2045. doi: 10.1002/1878-0261.12951. Fulltekst i vitenarkiv
  • Liu, Jingjing; van der Smissen, Wendy J. C. Prager; Collee, Margriet J.; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Vis alle 82 forfattere av denne artikkelen] (2020). Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. ISSN 2045-2322. 10:9688(1), s. 1–14. doi: 10.1038/s41598-020-65665-y. Fulltekst i vitenarkiv
  • Kramer, Iris; Hooning, Maartje J.; Mavaddat, Nasim; Hauptmann, Michael; Keeman, Renske & Steyerberg, Ewout W. [Vis alle 54 forfattere av denne artikkelen] (2020). Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. American Journal of Human Genetics. ISSN 0002-9297. 107(5), s. 837–848. doi: 10.1016/j.ajhg.2020.09.001.
  • Pladsen, Arne Valebjørg; Nilsen, Gro; Rueda, Oscar M.; Aure, Miriam Ragle; Borgan, Ørnulf & Liestøl, Knut [Vis alle 18 forfattere av denne artikkelen] (2020). DNA copy number motifs are strong and independent predictors of survival in breast cancer. Communications Biology. ISSN 2399-3642. 3. doi: 10.1038/s42003-020-0884-6. Fulltekst i vitenarkiv
  • Gythfeldt, Hedda von der Lippe; Lien, Tonje Gulbrandsen; Tekpli, Xavier; Silwal-Pandit, Laxmi; Borgen, Elin & Garred, Øystein [Vis alle 15 forfattere av denne artikkelen] (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer. International Journal of Cancer. ISSN 0020-7136. 147(9), s. 2515–2525. doi: 10.1002/ijc.33108. Fulltekst i vitenarkiv
  • Andersson, Yvonne; Inderberg, Else Marit ; Kvalheim, Gunnar; Herud, Morten Theodor Malmer; Engebråten, Olav & Flatmark, Kjersti [Vis alle 8 forfattere av denne artikkelen] (2019). Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patients. Acta Oncologica. ISSN 0284-186X. s. 1–7. doi: 10.1080/0284186X.2019.1704864.
  • Nome, Marianne Eikhom; Euceda, Leslie R.; Jabeen, Shakila; Debik, Julia; Bathen, Tone Frost & Giskeødegård, Guro F. [Vis alle 17 forfattere av denne artikkelen] (2019). Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers. International Journal of Cancer. ISSN 0020-7136. 146(1), s. 223–235. doi: 10.1002/ijc.32638. Fulltekst i vitenarkiv
  • Debik, Julia Barbara; Euceda, Leslie R.; Lundgren, Steinar; Gythfeldt, Hedda; Garred, Øystein & Borgen, Elin [Vis alle 9 forfattere av denne artikkelen] (2019). Assessing treatment response and prognosis by serum and tissue metabolomics in breast cancer patients. Journal of Proteome Research. ISSN 1535-3893. 18(10), s. 3649–3660. doi: 10.1021/acs.jproteome.9b00316. Fulltekst i vitenarkiv
  • Lindholm, Evita Maria; Aure, Miriam Ragle; Haugen, Mads Haugland; Sahlberg, Kristine Kleivi; Kristensen, Vessela N. & Nebdal, Daniel J.H. [Vis alle 9 forfattere av denne artikkelen] (2019). miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer. Molecular Oncology. ISSN 1574-7891. 13(10), s. 2278–2296. doi: 10.1002/1878-0261.12561. Fulltekst i vitenarkiv
  • Lai, Xiaoran; Geier, Oliver; Fleischer, Thomas; Garred, Øystein; Borgen, Elin & Funke, Simon Wolfgang [Vis alle 14 forfattere av denne artikkelen] (2019). Towards personalized computer simulation of breast cancer treatment: a multi-scale pharmacokinetic and pharmacodynamic model informed by multi-type patient data. Cancer Research. ISSN 0008-5472. 79(16), s. 4293–4304. doi: 10.1158/0008-5472.CAN-18-1804. Fulltekst i vitenarkiv
  • Møller, Elen Kristine; Nord, Silje; Wedge, David C; Lingjærde, Ole Christian; Silwal-Pandit, Laxmi & Gythfeldt, Hedda [Vis alle 19 forfattere av denne artikkelen] (2018). Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Medicine. ISSN 1756-994X. 10:92. doi: 10.1186/s13073-018-0601-y. Fulltekst i vitenarkiv
  • Fusser, Markus; Øverbye, Anders; Pandya, Abhilash D.; Mørch, Ýrr Asbjørg; Borgos, Sven Even F. & Kildal, Wanja [Vis alle 16 forfattere av denne artikkelen] (2018). Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. Journal of Controlled Release. ISSN 0168-3659. 293, s. 183–192. doi: 10.1016/j.jconrel.2018.11.029. Fulltekst i vitenarkiv
  • Bidard, François-Clément; Michiels, Stefan; Riethdorf, Sabine; Mueller, Volkmar; Esserman, Laura J. & Lucci, Anthony [Vis alle 50 forfattere av denne artikkelen] (2018). Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis. Journal of the National Cancer Institute. ISSN 0027-8874. 110(6), s. 560–567. doi: 10.1093/jnci/djy018.
  • Seip, Kotryna; Jørgensen, Kjetil; Haselager, Marco Vincent; Albrecht, Marco; Haugen, Mads Haugland & Egeland, Eivind Valen [Vis alle 11 forfattere av denne artikkelen] (2018). Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment. Cancer Letters. ISSN 0304-3835. 439, s. 1–13. doi: 10.1016/j.canlet.2018.09.023. Fulltekst i vitenarkiv
  • Jabeen, Shakila; Zucknick, Manuela; Nome, Marianne Eikhom; dannenfelser, ruth; Fleischer, Thomas & Kumar, Surendra [Vis alle 15 forfattere av denne artikkelen] (2018). Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab. Oncoimmunology. ISSN 2162-4011. 7(11), s. e1457598-1–e1457598-15. doi: 10.1080/2162402X.2018.1457598.
  • Prasmickaite, Lina; Tenstad, Ellen; Pettersen, Solveig; Jabeen, Shakila; Egeland, Eivind Valen & Nord, Silje [Vis alle 12 forfattere av denne artikkelen] (2018). Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4. Molecular Oncology. ISSN 1574-7891. 12(9), s. 1540–1558. doi: 10.1002/1878-0261.12319. Fulltekst i vitenarkiv
  • Saldova, Radka; Haakensen, Vilde Drageset; Rødland, Einar Andreas; Walsh, Ian; Stöckmann, Henning & Engebråten, Olav [Vis alle 7 forfattere av denne artikkelen] (2017). Serum N-glycome alterations in breast cancer during multimodal treatment and follow-up. Molecular Oncology. ISSN 1574-7891. 11(10), s. 1361–1379. doi: 10.1002/1878-0261.12105.
  • Øverbye, Anders; Holsæter, Ann Mari; Fusser, Markus; Skalko-Basnet, Natasa; Iversen, Tore Geir & Torgersen, Maria Lyngaas [Vis alle 12 forfattere av denne artikkelen] (2017). Ceramide-containing liposomes with doxorubicin: time and cell-dependent effect of C6 and C12 ceramide. OncoTarget. ISSN 1949-2553. 8(44), s. 76921–76934. doi: 10.18632/oncotarget.20217. Fulltekst i vitenarkiv
  • Silwal-Pandit, Laxmi; Nord, Silje; Gythfeldt, Hedda; Møller, Elen Kristine; Fleischer, Thomas & Rødland, Einar Andreas [Vis alle 25 forfattere av denne artikkelen] (2017). The longitudinal transcriptional response to neoadjuvant chemotherapy with and without bevacizumab in breast cancer. Clinical Cancer Research. ISSN 1078-0432. 23(16), s. 4662–4670. doi: 10.1158/1078-0432.CCR-17-0160. Fulltekst i vitenarkiv
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Engel, Jasper & Silwal-Pandit, Laxmi [Vis alle 14 forfattere av denne artikkelen] (2017). Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy. Metabolomics. ISSN 1573-3882. 13:37, s. 1–14. doi: 10.1007/s11306-017-1168-0. Fulltekst i vitenarkiv
  • Reinertsen, Kristin Valborg; Engebråten, Olav; Loge, Jon Håvard; Småstuen, Milada Cvancarova; Naume, Bjørn & Wist, Erik [Vis alle 10 forfattere av denne artikkelen] (2017). Fatigue During and After Breast Cancer Therapy—A Prospective Study. Journal of Pain and Symptom Management. ISSN 0885-3924. 53(3), s. 551–560. doi: 10.1016/j.jpainsymman.2016.09.011. Fulltekst i vitenarkiv
  • Kristian, Alexandr; Holtedahl, Jon Erik; Torheim, Turid K Gjerstad; Futsæther, Cecilia Marie; Hernes, Eivor & Engebråten, Olav [Vis alle 8 forfattere av denne artikkelen] (2017). Dynamic 2-Deoxy-2-[<sup>18</sup>F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts. Molecular Imaging and Biology. ISSN 1536-1632. 19(2), s. 271–279. doi: 10.1007/s11307-016-0998-x.
  • Sas-Chen, Aldema; Aure, Miriam Ragle; Leibovich, Limor; Carvalho, Silvia; Enuka, Yehoshua & Körner, Cindy [Vis alle 38 forfattere av denne artikkelen] (2016). LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Molecular Medicine. ISSN 1757-4676. 8(9), s. 1052–1064. doi: 10.15252/emmm.201606198. Fulltekst i vitenarkiv
  • Easton, Douglas F; Lesueur, Fabienne; Decker, Brennan; Michailidou, Kyriaki; Li, Jun & Allen, Jamie [Vis alle 149 forfattere av denne artikkelen] (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: Implications for gene panel testing. Journal of Medical Genetics. ISSN 0022-2593. 53(5), s. 298–309. doi: 10.1136/jmedgenet-2015-103529.
  • Kim, Eugene; Tunset, Hanna Maja; Cebulla, Jana; Vettukattil, Muhammad Riyas; Helgesen, Heidi & Feuerherm, Astrid Jullumstrø [Vis alle 10 forfattere av denne artikkelen] (2016). Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. BMC Cancer. ISSN 1471-2407. 16:191. doi: 10.1186/s12885-016-2225-1. Fulltekst i vitenarkiv
  • Andersson, Yvonne; Engebråten, Olav; Juell, Siri; Aamdal, Steinar; Brunsvig, Paal Fr. & Fodstad, Øystein [Vis alle 7 forfattere av denne artikkelen] (2015). Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin. British Journal of Cancer. ISSN 0007-0920. 113(11), s. 1548–1555. doi: 10.1038/bjc.2015.380.
  • Pfister, Neil T.; Fomin, Vitalay; Regunath, Kausik; Zhou, Jeffrey Y.; Zhou, Wen & Silwal-Pandit, Laxmi [Vis alle 18 forfattere av denne artikkelen] (2015). Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells. Genes & Development. ISSN 0890-9369. 29(12), s. 1298–1315. doi: 10.1101/gad.263202.115.
  • Bagheri Fam, Shahla; Skjeldal, Frode Miltzow; Griffiths, Gareth Wyn; Mælandsmo, Gunhild; Engebråten, Olav & Nyström, Bo [Vis alle 8 forfattere av denne artikkelen] (2015). pH-Responsive Nano Carriers for Doxorubicin Delivery. Pharmaceutical Research. ISSN 0724-8741. 32(4), s. 1249–1263. doi: 10.1007/s11095-014-1530-0.
  • Esmaeili, Morteza; Moestue, Siver Andreas; Hamans, Bob C.; Veltien, Andor; Kristian, Alexandr & Engebråten, Olav [Vis alle 10 forfattere av denne artikkelen] (2015). In vivo 31P MRSI for metabolic profiling of human breast cancer xenografts. Journal of Magnetic Resonance Imaging. ISSN 1053-1807. 41(3), s. 601–609. doi: 10.1002/jmri.24588. Fulltekst i vitenarkiv
  • Skrbo, Nirma; Hjortland, Geir Olav; Kristian, Alexandr; Holm, Ruth; Nordgard, Silje H. & Prasmickaite, Lina [Vis alle 10 forfattere av denne artikkelen] (2014). Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft. PLOS ONE. ISSN 1932-6203. 9(11). doi: 10.1371/journal.pone.0113278. Fulltekst i vitenarkiv
  • Nilsen, Line; Fangberget, Anne; Geier, Oliver; Engebråten, Olav; Borgen, Elin & Olsen, Dag Rune [Vis alle 7 forfattere av denne artikkelen] (2014). Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis. Journal of Magnetic Resonance Imaging. ISSN 1053-1807. 40(6), s. 1382–1391. doi: 10.1002/jmri.24502.
  • Kristian, Alexandr; Riss, Patrick; Qu, Hong; Milde, Mona; Schoultz, Bent Wilhelm & Engebråten, Olav [Vis alle 8 forfattere av denne artikkelen] (2014). Positron emission tomography and pharmacokinetics of 2-[18F]-fluoroethyl choline for metabolic studies in breast cancer xenografts. Acta Oncologica. ISSN 0284-186X. 53(8), s. 1086–1092. doi: 10.3109/0284186X.2014.934398.
  • Lindholm, Evita Maria; Krohn, Marit; Iadevaia, Sergio; Kristian, Alexandr; Mills, Gordon B. & Mælandsmo, Gunhild [Vis alle 7 forfattere av denne artikkelen] (2014). Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations. Clinical Cancer Research. ISSN 1078-0432. 20(2), s. 404–412. doi: 10.1158/1078-0432.CCR-13-1865.
  • Grinde, Maria Tunset; Skrbo, Nirma; Moestue, Siver Andreas; Rødland, Einar Andreas; Borgan, Eldrid & Kristian, Alexandr [Vis alle 13 forfattere av denne artikkelen] (2014). Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Research. ISSN 1465-5411. 16(1). doi: 10.1186/bcr3597. Fulltekst i vitenarkiv
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2014). Quantitative 31P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts. Magnetic Resonance in Medicine. ISSN 0740-3194. 71(6), s. 1973–1981. doi: 10.1002/mrm.24869. Fulltekst i vitenarkiv
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Bofin, Anna M.; Engebråten, Olav & Mælandsmo, Gunhild [Vis alle 8 forfattere av denne artikkelen] (2013). Low-molecular contrast agent DCE-MRI and DW-MRI in early assessment of bevacizumab treatment in breast cancer xenografts. Journal of Magnetic Resonance Imaging. ISSN 1053-1807. 38(5), s. 1043–1053. doi: 10.1002/jmri.24079.
  • Borgan, Eldrid; Lindholm, Evita Maria; Moestue, Siver Andreas; Mælandsmo, Gunhild; Lingjærde, Ole Christian & Gribbestad, Ingrid S [Vis alle 9 forfattere av denne artikkelen] (2013). Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts. Molecular Oncology. ISSN 1574-7891. 7(1), s. 130–142. doi: 10.1016/j.molonc.2012.10.005. Fulltekst i vitenarkiv
  • Moestue, Siver Andreas; Dam, Cornelia Gerarda; Gorad, Saurabh Sayajirao; Kristian, Alexandr; Bofin, Anna M. & Mælandsmo, Gunhild [Vis alle 9 forfattere av denne artikkelen] (2013). Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Research. ISSN 1465-5411. 15(1).
  • Kristian, Alexandr; Nilsen, Line; Røe, Kathrine; Revheim, Mona Elisabeth; Engebråten, Olav & Mælandsmo, Gunhild [Vis alle 9 forfattere av denne artikkelen] (2013). Dynamic 18F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts. Nuclear medicine and molecular imaging. ISSN 1869-3474. 47, s. 173–180. doi: 10.1007/s13139-013-0211-y.
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Qu, Hong; Mælandsmo, Gunhild; Engebråten, Olav & Seierstad, Therese [Vis alle 7 forfattere av denne artikkelen] (2013). Dynamic F-18-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts. Acta Oncologica. ISSN 0284-186X. 52(7), s. 1566–1572. doi: 10.3109/0284186X.2013.813634.
  • Engebråten, Olav; Vollan, Hans Kristian Moen & Børresen-Dale, Anne-Lise (2013). Triple-negative breast cancer and the need for new therapeutic targets. American Journal of Pathology. ISSN 0002-9440. 183(4), s. 1064–1074. doi: 10.1016/j.ajpath.2013.05.033.
  • Moestue, Siver Andreas; Dam, Cornelia Gerarda; Gorad, Saurabh Sayajirao; Kristian, Alexandr; Bofin, Anna M. & Mælandsmo, Gunhild [Vis alle 9 forfattere av denne artikkelen] (2013). Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Research. ISSN 1465-5411. 15(1:R16). doi: 10.1186/bcr3391. Fulltekst i vitenarkiv
  • Engesæter, Birgit Øvstebø; Engebråten, Olav; Flørenes, Vivi Ann & Mælandsmo, Gunhild (2012). Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma. PLOS ONE. ISSN 1932-6203. 7(9). doi: 10.1371/journal.pone.0045492. Fulltekst i vitenarkiv
  • Lindholm, Evita Maria; Kristian, Alexandr; Nalwoga, Hawa; Kruger, Kristi; Nygård, Ståle & Akslen, Lars A. [Vis alle 8 forfattere av denne artikkelen] (2012). Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts. Molecular Oncology. ISSN 1574-7891. 6(4), s. 418–427. doi: 10.1016/j.molonc.2012.03.006. Fulltekst i vitenarkiv
  • Huuse, Else Marie; Moestue, Siver Andreas; Lindholm, Evita Maria; Bathen, Tone Frost; Nalwoga, Hawa & Krüger, Kristi [Vis alle 11 forfattere av denne artikkelen] (2012). In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. Journal of Magnetic Resonance Imaging. ISSN 1053-1807. 35(5), s. 1098–1107. doi: 10.1002/jmri.23507.
  • Engebråten, Olav; Edvardsen, Hege; Løkkevik, Erik; Naume, Bjørn; Kristensen, Vessela N. & Ottestad, Lars [Vis alle 7 forfattere av denne artikkelen] (2012). Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. ISRN Oncology. ISSN 2090-5661. doi: 10.5402/2012/176789.
  • Grinde, Maria Tunset; Moestue, Siver Andreas; Borgan, Eldrid; Risa, Øystein; Engebråten, Olav & Gribbestad, Ingrid S (2011). 13C High-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns. NMR in Biomedicine. ISSN 0952-3480. 24(10), s. 1243–1252. doi: 10.1002/nbm.1683.
  • Engesæter, Birgit Øvstebø; Sathermugathevan, Menaka; Hellesnes, Tina; Engebråten, Olav; Holm, Ruth & Flørenes, Vivi Ann [Vis alle 7 forfattere av denne artikkelen] (2011). Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells. Cancer Biology & Therapy. ISSN 1538-4047. 12(1), s. 47–58. doi: 10.4161/cbt.12.1.15714.
  • Fangberget, Anne; Nilsen, Line; Hole, Knut Håkon; Holmen, Marit Muri; Engebråten, Olav & Naume, Bjørn [Vis alle 9 forfattere av denne artikkelen] (2011). Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. European Radiology. ISSN 0938-7994. 21(6), s. 1188–1199. doi: 10.1007/s00330-010-2020-3.
  • Moestue, Siver Andreas; Engebråten, Olav & Gribbestad, Ingrid S (2011). Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy. Molecular Oncology. ISSN 1574-7891. 5(3), s. 224–241. doi: 10.1016/j.molonc.2011.04.001. Fulltekst i vitenarkiv
  • Moestue, Siver Andreas; Borgan, Eldrid; Huuse, Else Marie; Lindholm, Evita Maria; Sitter, Beathe & Børresen-Dale, Anne-Lise [Vis alle 9 forfattere av denne artikkelen] (2010). Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer. ISSN 1471-2407. 10. doi: 10.1186/1471-2407-10-433.

Se alle arbeider i Cristin

  • Fusser, Markus; Øverbye, Anders; Pandya, Abhilash D.; Mørch, Ýrr Asbjørg; Borgos, Sven Even F. & Kildal, Wanja [Vis alle 16 forfattere av denne artikkelen] (2022). Corrigendum to “Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft”, [Journal of Control Release, 293 (2019) 183–192, (Journal of Control Release, (2019) 293(183-192) (S0168365918306928), (10.1016/j.jconrel.2018.11.029)). Journal of Controlled Release. ISSN 0168-3659. 349. doi: 10.1016/j.jconrel.2022.06.040.
  • Frigessi Di Rattalma, Arnoldo; Köhn-Luque, Alvaro; Kristensen, Vessela N.; Gørbitz, Carl Henrik & Engebråten, Olav (2020). Kan statistikk og matematikk redde like mange liv som nye medisiner? Aftenposten (morgenutg. : trykt utg.). ISSN 0804-3116.
  • Christoffersen, Thoralf; Helland, Åslaug; Engebråten, Olav; Straume, Oddbjørn & Guren, Tormod Kyrre (2016). Signalhemmere. I Dahl, Olav; Lehne, Gustav & Christoffersen, Thoralf (Red.), Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. Universitetet i Oslo. ISSN 978-82-992331-4-9. s. 282–328.
  • Kim, Eugene; Kim, Jana; Feuerherm, Astrid Jullumstrø; Engebråten, Olav; Mælandsmo, Gunhild & Johansen, Berit [Vis alle 7 forfattere av denne artikkelen] (2016). Different anti-angiogenic drugs have different effects on the relationship between vascular structure and function in a patient-derived breast cancer model.
  • Skrbo, Nirma; Kirik, U.; Kristian, Alexandr; Cifani, P.; Antberg, L. & Moestue, Siver Andreas [Vis alle 11 forfattere av denne artikkelen] (2016). Protein expression analysis of intratumor heterogeneity in a luminal-like breast cancer xenograft.
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Postma, Geert & Engel, Jasper [Vis alle 10 forfattere av denne artikkelen] (2015). Evaluation of neoadjuvant chemotherapy in breast cancer using MR metabolomics.
  • Kim, Eugene; Feuerherm, Astrid Jullumstrø; Johansen, Berit; Engebråten, Olav; Mælandsmo, Gunhild & Bathen, Tone Frost [Vis alle 7 forfattere av denne artikkelen] (2015). cPLA2 Inhibition Affects the Relationship Between Vascular Function and Structure in a Patient-Derived Breast Cancer Model: A Correlation Study of DCE-MRI Vs. Micro-CT.
  • Euceda, Leslie R.; Haukaas, Tonje Husby; Giskeødegård, Guro F.; Vettukattil, Muhammad Riyas; Engel, Jasper & Postma, Geert [Vis alle 10 forfattere av denne artikkelen] (2015). Evaluation of neoadjuvant chemotherapy in breast cancer using MR metabolomics.
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Qu, Hong; Mælandsmo, Gunhild; Engebråten, Olav & Malinen, Eirik (2014). Dynamic 18F-FDG PET parameters variation in patient-derived breast cancer xenograft and correlation with outcome following treatment with cytotoxic agents. Cancer Research. ISSN 0008-5472. 74. doi: 10.1158/1538-7445.AM2014-2053.
  • Kristian, Alexandr; Riss, Patrick; Qu, Hong; Milde, Mona; Schoultz, Bent Wilhelm & Engebråten, Olav [Vis alle 8 forfattere av denne artikkelen] (2014). Pharmacokinetic modeling of dynamic 18F‐Choline PET reflects choline metabolism in breast carcinoma xenografts.
  • Kristian, Alexandr; Revheim, Mona Elisabeth; Mælandsmo, Gunhild; Engebråten, Olav & Malinen, Eirik (2014). Variation in dynamic 18FFDG PET parameters in breast cancer PDX and correlation to treatment outcome. Radiotherapy and Oncology. ISSN 0167-8140. 111, s. 387–387.
  • Mathiesen, Randi R.; Borgen, Elin; Sætersdal, Anna Barbro; Fangberget, Anne; Schirmer, Cecilie & Stav, I [Vis alle 10 forfattere av denne artikkelen] (2013). Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant breast cancer treatment including bevacizumab.
  • Møller, Elen Kristine; Vollan, Hans Kristian Moen; Nord, Silje; von der Lippe Gythfeldt, H; Edvardsen, Hege & Silwal-Pandit, Laxmi [Vis alle 20 forfattere av denne artikkelen] (2013). A time course study of genomic instability in breast cancer patients receiving neoadjuvant chemotherapy with or without bevacizumab.
  • Engebråten, Olav; Vaske, Charles J.; Krohn, Marit; Silwal-Pandit, Laxmi; Vollan, Hans Kristian Moen & Møller, Elen Kristine [Vis alle 20 forfattere av denne artikkelen] (2013). Molecular response in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - A randomized study.
  • Moestue, Siver Andreas; Grinde, Maria Tunset; Marangoni, Eilsabetta; Sørlie, Therese; Engebråten, Olav & Mælandsmo, Gunhild [Vis alle 8 forfattere av denne artikkelen] (2013). Cytosolic phospholipase A2 (cPLA2) as a therapeutic target in basal-like breast cancer.
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2013). Quantitative 31P Magnetic Resonance Spectroscopy Stratifies Treatment Response to a PI3K/mTOR Inhibitor in Two Distinct Breast Cancer Xenografts.
  • Esmaeili, Morteza; Bathen, Tone Frost; Engebråten, Olav; Mælandsmo, Gunhild; Gribbestad, Ingrid S & Moestue, Siver Andreas (2013). Quantitative 31P Magnetic Resonance Spectroscopy Stratifies Treatment Response to a PI3K/mTOR Inhibitor in Two Distinct Breast Cancer Xenografts.
  • Moestue, Siver Andreas; Grinde, Maria Tunset; Marangoni, Elisabetta; Skrbo, Nirma; Rødland, Einar Andreas & Borgan, Eldrid [Vis alle 14 forfattere av denne artikkelen] (2013). Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
  • Moestue, Siver Andreas; Flatabø, Silje; Huuse, Else Marie; Lindholm, Evita Maria; Engebråten, Olav & Akslen, Lars A. [Vis alle 8 forfattere av denne artikkelen] (2012). Metabolic responses to VEGF inhibition in patient-derived breast cancer xenografts.
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Engebråten, Olav; Akslen, Lars A. & Mælandsmo, Gunhild [Vis alle 7 forfattere av denne artikkelen] (2011). DCE-MRI for early therapy monitoring of anti-angiogenic therapy.
  • Huuse, Else Marie; Moestue, Siver Andreas; Bathen, Tone Frost; Bofin, Anna M.; Mælandsmo, Gunhild & Akslen, Lars A. [Vis alle 8 forfattere av denne artikkelen] (2011). In vivo Dynamic Contrast Enhanced MRI & Histopathological Assessment of Tumor Angiogenesis in Luminal-like and Basal-like Breast Cancer Xenografts.
  • Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria; Akslen, Lars A.; Engebråten, Olav & Mælandsmo, Gunhild [Vis alle 7 forfattere av denne artikkelen] (2011). Early vascular response to bevacizumab treatment measured by DCE-MRI in breast cancer xenografts.
  • Prasmickaite, Lina; Skrbo, Nirma; Høifødt, Hanne Kleppe; Suo, Zhenhe; Engebråten, Olav & Gullestad, Hans petter [Vis alle 9 forfattere av denne artikkelen] (2010). Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells. Pigment Cell & Melanoma Research. ISSN 1755-1471. 23(3), s. 449–451. doi: 10.1111/j.1755-148X.2010.00690.x.

Se alle arbeider i Cristin

Publisert 13. apr. 2011 11:37 - Sist endret 5. nov. 2015 13:08